Skip to main content


September 13, 2013

Lehman’s legacy: Five bitter pills

When you treat a sick patient,” says Tom Huertas, “the medicine might not work straight away. But that doesn’t mean it’s not the right treatment.”

Mr Huertas, formerly a member of the Basel Committee on Banking Supervision and now a partner with EY, is convinced that the regulatory reforms targeting banks since the collapse of Lehman Brothers in 2008 are the right prescription. They include tougher capital and liquidity requirements as well as prospective new rules on winding up broken lenders.“/Those big fixes, combined with a more intrusive style of supervision of the banks, and the risks they are taking, should make the system pretty robust,” says Mr Huertas.

But some reformers are not convinced. They insist that many of the changes amount to tinkering with existing rules with an eye on the most recent crisis, while far more should be done to pre-empt the next potential meltdown.



Read the full Financial Times article here

In the News


For media inquiries, please contact us at or 202-618-6433.

Contact Us

For media inquiries, please contact or 202-618-6433.

To sign up for our email newsletter, please visit this page.

This field is for validation purposes and should be left unchanged.

Sign Up — Stay Informed With Our Monthly Newsletter

"* (Required)" indicates required fields

This field is for validation purposes and should be left unchanged.

For media inquiries,

please contact or 202-618-6433.


Help us fight for the public interest in our financial markets, protecting Main Street from Wall Street and avoiding another costly financial collapse and economic crisis, by making a donation today.

Donate Today